Geron Corp (NASDAQ:GERN)
| 3.60 Delayed Data As of Jun 02 |  +0.215 / +6.36%Today’s Change | 1.18 Today|||52-Week Range 3.84 | +48.55% Year-to-Date |
Latest GERN News | Press Releases
| Geron (GERN) Just Flashed Golden Cross Signal: Do You Buy? Jun 01 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.38 |
| Today’s open | 3.45 |
| Day’s range | 3.39 - 3.67 |
| Volume | 708,746 |
| Average volume (3 months) | 5,601,225 |
| Market cap | $1.7B |
Data as of 4:00pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | -5.14% |
| Earnings growth (this year) | -0.90% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -57.21% |
| P/E ratio | NM |
| Price/Sales | 1,546.14 |
| Price/Book | 15.93 |
Competitors
Data as of 4:00pm ET, 06/02/2023
Financials
| Next reporting date | August 2, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $596.0K |
| Annual profit (last year) | -$141.9M |
| Net profit margin | -23,808.89% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
